Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CA2 | P00918 | 2/20 | 0.62 |
| ▸ | CA4 | P22748 | 1/20 | 0.62 |
| ▸ | CA5A | P35218 | 1/20 | 0.62 |
| ▸ | CFTR | P13569 | 1/20 | 0.54 |
| ▸ | ALOX15 | P16050 | 1/20 | 0.50 |
| ▸ | TSHR | P16473 | 1/20 | 0.50 |
| ▸ | ALDH1A1 | P00352 | 3/20 | 0.48 |
| ▸ | MEN1 | O00255 | 1/20 | 0.48 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.48 |
| ▸ | GAA | P10253 | 2/20 | 0.44 |
| ▸ | USP2 | O75604 | 1/20 | 0.44 |
| ▸ | ESR1 | P03372 | 1/20 | 0.44 |
| ▸ | SRC | P12931 | 2/20 | 0.42 |
| ▸ | MAPT | P10636 | 2/20 | 0.42 |
| ▸ | HSD17B10 | Q99714 | 1/20 | 0.42 |
| ▸ | PTPN1 | P18031 | 1/20 | 0.41 |
| ▸ | TDP1 | Q9NUW8 | 1/20 | 0.41 |
| ▸ | L3MBTL1 | Q9Y468 | 1/20 | 0.41 |
| ▸ | ALPG | P10696 | 1/20 | 0.41 |
| ▸ | ALOX12 | P18054 | 1/20 | 0.41 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| Ammonia Solution, Strong SCHEMBL10908266 | 0.97 | CA2 (0.59) | CA2CA4CA5ACFTRALOX15 | |
| SCHEMBL7466860 | 0.83 | CA2 (0.62) | CA2CA4CA5ACFTRALOX15 | |
| Phenylphosphonic Acid SCHEMBL269853 | 0.77 | CA2 (1.00) | CA2CA4CA5ACFTRALOX15 | |
| SCHEMBL191567 | 0.77 | CA2 (0.68) | CA2CA4CA5ACFTRALOX15 | |
| SCHEMBL1382564 | 0.77 | CA2 (0.52) | CA2CA4CA5ACFTRALOX15 | |
| Phenylphosphonic Acid SCHEMBL28151870 | 0.77 | CA2 (1.00) | CA2CA4CA5ACFTRALOX15 | |
| SCHEMBL7079874 | 0.77 | CA2 (0.52) | CA2CA4CA5ACFTRALOX15 | |
| Phenylphosphonic Acid SCHEMBL34998 | 0.77 | CA2 (1.00) | CA2CA4CA5ACFTRALOX15 | |
| Phenylphosphonic Acid SCHEMBL2790969 | 0.74 | CA2 (0.94) | CA2CA4CA5ACFTRALOX15 | |
| Phenylphosphonic Acid SCHEMBL20140614 | 0.74 | CA2 (0.94) | CA2CA4CA5ACFTRALOX15 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 87 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-118179550-A | Catalyst for supporting alkali metal and preparation method and application thereof | 中国科学院大连化学物理研究所 | 2024-06-14 | — | — | CN | claimed |
| CN-109280164-A | A kind of coating material and preparation method thereof with ultra-hydrophobicity | 南京艾利克斯电子科技有限公司 | 2019-01-29 | — | — | CN | claimed |
| CN-109212404-A | A kind of remittance energy maintainability test instrument | 南京艾利克斯电子科技有限公司 | 2019-01-15 | — | — | CN | claimed |
| CN-109159656-A | A kind of windshield sunshading cover | 南京昊铭远科信息科技有限公司 | 2019-01-08 | — | — | CN | claimed |
| CN-109030917-A | A kind of digital high-voltage electroscope | 南京艾利克斯电子科技有限公司 | 2018-12-18 | — | — | CN | claimed |
| CN-118179550-A | Catalyst for supporting alkali metal and preparation method and application thereof | 中国科学院大连化学物理研究所 | 2024-06-14 | — | — | CN | disclosed |
| CN-112334797-B | Polarizer and image display device | 富士胶片株式会社 | 2022-12-20 | — | — | CN | disclosed |
| CN-115136042-A | Optical laminate and display device | 富士胶片株式会社 | 2022-09-30 | — | — | CN | disclosed |
| CN-114502996-A | Optical laminate, organic EL display device, and folding device | 富士胶片株式会社 | 2022-05-13 | — | — | CN | disclosed |
| CN-113490543-A | Polymer and method for producing same, gas separation membrane, gas separation module, and gas separation device using same, and m-phenylenediamine compound | 富士胶片株式会社 | 2021-10-08 | — | — | CN | disclosed |
| US-10905769-B2 | Peptide and peptide mimetic binding antagonists of polo-like kinase 1 polo box domain and methods of use | THE UNITED STATES OF AMERICA, AS REPRESENTED BY THE SECRETARY, DEPARTMENT OF HEALTH & HUMAN SERVICES (US) | 2021-02-02 | — | — | US | disclosed |
| CN-110183461-A | Cortex chalone analog and its synthesis and purposes | 哈佛学院院长等 | 2019-08-30 | — | — | CN | disclosed |
| US-6017905-A | TREATMENT OF HYPERCHOLESTEROLEMIA AND ATHEROSCLEROSIS | WARNER-LAMBERT COMPANY (US) | 2000-01-25 | — | — | US | disclosed |
| US-5807846-A | TREATING HYPERCHOLESTEROLEMIA AND ATHEROSCLEROSIS | WARNER-LAMBERT COMPANY (US) | 1998-09-15 | — | — | US | disclosed |
| US-5792444-A | ADMINISTERING LABELED CHEMOTACTIC PEPTIDE WHICH ACCUMULATES AT SITE OF INFECTION OR INFLAMMATION | THE GENERAL HOSPITAL CORPORATION (US) | 1998-08-11 | — | — | US | disclosed |
| US-4563310-A | HERBICIDES | ZOECON CORPORATION (US) | 1986-01-07 | — | — | US | disclosed |
| US-4520197-A | Tetrahydrobenzodiazaphosphorindiones and tetrahydropyridodiazaphosphorindiones | ZOECON CORPORATION (US) | 1985-05-28 | — | — | US | disclosed |
| US-4433149-A | Esters of ureido-phenyl (or pyridyl) phosphinic acids | ZOECON CORPORATION (US) | 1984-02-21 | — | — | US | disclosed |
| EP-0065374-A1 | Substituted phosphinates and phosphinothioates and their use for the control of weeds | ZOECON CORPORATION (US) | 1982-11-24 | — | — | EP | disclosed |
| US-3933864-A | Process for preparing glycidonitriles | THE UPJOHN COMPANY (US) | 1976-01-20 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-10905769-B2 | Peptide and peptide mimetic binding antagonists of polo-like kinase 1 polo box domain and methods of use | PLK1, POLR1E, POLK | CA2 4383/4885CA4 4674/4885CA5A 3709/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.